经导管主动脉瓣置换术前肠系膜动脉狭窄与肠系膜缺血的影响
本研究对269例连续接受经导管主动脉瓣置换术的患者进行前瞻性随访,评估急性肠系膜缺血的发生率、病因及后果,以及术前肠系膜动脉狭窄70%或以上的影响。中位随访33.3个月,7例(2.6%)确诊急性肠系膜缺血,死亡率为100%。术前肠系膜动脉狭窄70%或以上与1年全因死亡率升高独立相关(校正HR 3.78;95%CI 1.74-8.19;P=0.001)。
要点
- 急性肠系膜缺血发生率为2.6%,死亡率为100%。
- 术前肠系膜动脉狭窄70%或以上与急性肠系膜缺血独立相关。
- 术前肠系膜动脉狭窄70%或以上者1年全因死亡风险升高(校正HR 3.78)。
核心结论
- 急性肠系膜缺血是经导管主动脉瓣置换术后30天死亡的重要原因,临床不稳定时应考虑此诊断,尤其但不仅限于术前存在肠系膜动脉狭窄者。
- 鉴于急性肠系膜缺血预后极差,作者建议对所有拟行经导管主动脉瓣置换术的患者常规评估肠系膜动脉狭窄。
研究设计与样本
- 对269例连续接受经导管主动脉瓣置换术的患者进行前瞻性随访,通过腹部计算机断层扫描确诊急性肠系膜缺血,并根据术前计算机断层扫描血管造影是否存在肠系膜动脉狭窄70%或以上分析1年全因和心血管死亡的累积风险。
主要发现
- 中位随访33.3个月(四分位距15.0-61.0个月),7例(2.6%)确诊急性肠系膜缺血;其中既往狭窄肠系膜动脉的血栓性闭塞4例(57.1%),栓塞性急性肠系膜缺血占其余病例(42.9%)。
- 急性肠系膜缺血死亡率为100%。
- 30天时,急性肠系膜缺血死亡占全因死亡的40%,占心血管死亡的67%。
- 多变量分析显示,较高的胸外科医师协会评分和肠系膜动脉狭窄70%或以上与急性肠系膜缺血独立相关。
- 32例(11.9%)术前肠系膜动脉狭窄70%或以上的患者经导管主动脉瓣置换术后1年全因死亡风险升高(校正风险比3.78;95%置信区间1.74-8.19;P=0.001)。
临床怎么用
- 作者建议对所有拟行经导管主动脉瓣置换术的患者常规评估肠系膜动脉狭窄。
- 作者认为经导管主动脉瓣置换术后临床不稳定的患者应考虑急性肠系膜缺血,尤其但不仅限于术前存在肠系膜动脉狭窄者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to examine the incidence, etiologies, and consequences of acute mesenteric ischemia as well as the impact of preprocedural subclinical mesenteric artery stenosis in patients undergoing transcatheter aortic valve replacement. METHODS: Among prospective follow-up of 269 consecutive patients undergoing transcatheter aortic valve replacement, diagnosis of acute mesenteric ischemia was confirmed by abdominal computed tomography. Cumulative hazard of 1-year all-cause and cardiovascular mortality according to the absence or presence of mesenteric artery stenosis 70% or greater from preprocedural computed tomography angiography was analyzed. RESULTS: Acute mesenteric ischemia was confirmed in 7 patients (2.6%) during mid-term (median, 33.3 months, interquartile range, 15.0-61.0 months) follow-up. Thrombotic occlusions of previously stenotic mesenteric arteries account for 4 cases (57.1%), and embolic acute mesenteric ischemia constitute the rest (42.9%) of the cases. The mortality rate of acute mesenteric ischemia was 100%. At 30 days, death from acute mesenteric ischemia accounts for 40% of all-cause mortality and 67% of cardiovascular death. By multivariable analysis, higher Society of Thoracic Surgeons score and mesenteric artery stenosis 70% or greater were independently associated with acute mesenteric ischemia. Thirty-two patients (11.9%) with preprocedural mesenteric artery stenosis 70% or greater had an increased risk of all-cause mortality (adjusted hazard ratio, 3.78; 95% confidence interval, 1.74-8.19; P = .001) at 1 year after transcatheter aortic valve replacement. CONCLUSIONS: Acute mesenteric ischemia, an important cause of 30-day mortality, should be considered in patients who become clinically unstable after transcatheter aortic valve replacement, particularly but not exclusively in those with preexisting mesenteric artery stenosis. Mesenteric artery stenosis should be routinely assessed in all patients who are indicated for transcatheter aortic valve replacement considering the dismal prognosis of acute mesenteric ischemia.
引用
- Chen JH, Chen YH, Chang HH, et al. Impact of preprocedural mesenteric artery stenosis and mesenteric ischemia in patients undergoing transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2022. PMID: 35469598. doi:10.1016/j.jtcvs.2022.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。